Manufacture of pharmaceutical preparations
PALLA PHARMA NORWAY HOLDING AS
Operating profit
NOK −14,000
Equity
NOK 91.0m
Incorporated
2017
Share capital
NOK 2.2m
Roles
Regnskapsfører
Revisor
Styrets lederMorten Andresen
StyremedlemLars Markus Solheim
StyremedlemHalvor Weider
StyremedlemAndrew Howatson
StyremedlemPreben René Hjallum
Auditor
Auditor at related companies
None of the 1 related companies use the same auditor.
| Company | Auditor | |
|---|---|---|
| PALLA PHARMA NORWAY AS | RSM NORGE AS | different |
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| MA-INVEST AS | 31.2% | 6953.000000 | 2025 |
| KILEN EIENDOM AS | 17.2% | 3829.000000 | 2025 |
| LMS HOLDCO AS | 10.9% | 2432.000000 | 2025 |
| HALVOR WEIDER | 8.4% | 1875.000000 | 2025 |
| MARITOPPEN INVEST AS | 8.4% | 1875.000000 | 2025 |
| HOLGER INVEST I AS | 5.4% | 1206.000000 | 2025 |
| PALLA PHARMA ANSATTFORENING | 4.4% | 987.000000 | 2025 |
| HJALLUM HOLDING AS | 2.4% | 542.000000 | 2025 |
| HARALD NORVIK INSIGHT AS | 1.8% | 411.000000 | 2025 |
| SVEIN ARNE WALLE | 1.4% | 310.000000 | 2025 |
| PHARMORE AS | 0.9% | 206.000000 | 2025 |
| ALF BJARNE GUNDERSEN | 0.5% | 115.000000 | 2025 |
| ØISTEIN TOVSEN | 0.5% | 113.000000 | 2025 |
| PHARMCONSULT AS | 0.5% | 111.000000 | 2025 |
| BERNT KÅRE VILDALEN | 0.5% | 103.000000 | 2025 |
| OVE GUNDERSEN | 0.5% | 103.000000 | 2025 |
| FINN ASBJØRN SØRENSEN | 0.5% | 102.000000 | 2025 |
| KARIN BJUNE SVEEN | 0.4% | 91.000000 | 2025 |
| MARIANNE ERLUND | 0.1% | 32.000000 | 2025 |
| SONDRE JOHNSEN | 0.1% | 31.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| PALLA PHARMA NORWAY AS | Active | 100.0% | 30000.000000 |
| PALLA PHARMA EIENDOM AS | Active | 100.0% | 3000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.